Cordycepin: A bioactive metabolite with therapeutic potential

被引:255
作者
Tuli, Hardeep S. [1 ]
Sharma, Anil K. [1 ]
Sandhu, Sardul S. [2 ]
Kashyap, Dharambir [3 ]
机构
[1] Maharishi Markandeshwar Univ, Dept Biotechnol, Mullana Ambala 133203, Haryana, India
[2] Rani Durgavati Univ, Dept Biol Sci, Jabalpur 482001, India
[3] PGIMER, Dept Histopathol, Chandigarh, Punjab, India
关键词
Cordyceps; Metabolite; Cordycepin; Mechanism; Therapeutic potential; HUMAN PLATELET-AGGREGATION; BREAST-CANCER CELLS; INDUCED MATRIX-METALLOPROTEINASE-9 EXPRESSION; ASCITES-TUMOR CELLS; MATRIX METALLOPROTEINASES; ESTROGEN-RECEPTOR; CARCINOMA-CELLS; TNF-ALPHA; INHIBITION; INTERLEUKIN-10;
D O I
10.1016/j.lfs.2013.09.030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Cytotoxic nucleoside analogues were the first chemotherapeutic agents for cancer treatment. Cordycepin, an active ingredient of the insect fungus Cordyceps militaris, is a category of compounds that exhibit significant therapeutic potential. Cordycepin has many intracellular targets, including nucleic acid (DNA/RNA), apoptosis and cell cycle, etc. Investigations of the mechanism of anti-cancer drugs have yielded important information for the design of novel drug targets in order to enhance anti-tumor activity with less toxicity to patients. This extensive review covers various molecular aspects of cordycepin interactions with its recognized cellular targets and proposes the development of novel therapeutic strategies for cancer treatment. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:863 / 869
页数:7
相关论文
共 69 条
[1]   Cancer cell: using inflammation to invade the host [J].
Arias, Jose-Ignacio ;
Aller, Maria-Angeles ;
Arias, Jaime .
MOLECULAR CANCER, 2007, 6 (1)
[2]   Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes [J].
Armstrong, L ;
Jordan, N ;
Millar, A .
THORAX, 1996, 51 (02) :143-149
[3]  
Baik JS, 2012, INDIAN J BIOCHEM BIO, V49, P86
[4]   The platelet contribution to cancer progression [J].
Bambace, N. M. ;
Holmes, C. E. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (02) :237-249
[5]  
Cai W., 2011, Chin. J. Clin. (Electron. Ed.), V5, P4048
[6]   Oestrogen receptor negative breast cancers exhibit high cytokine content [J].
Chavey, Carine ;
Bibeau, Frederic ;
Gourgou-Bourgade, Sophie ;
Burlinchon, Sandrine ;
Boissiere, Florence ;
Laune, Daniel ;
Roques, Sylvie ;
Lazennec, Gwendal .
BREAST CANCER RESEARCH, 2007, 9 (01)
[7]   RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells [J].
Chen, Lisa S. ;
Stellrecht, Christine M. ;
Gandhi, Varsha .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 140 (06) :682-691
[8]   Cordycepin (3′-deoxyadenosine) inhibits human platelet aggregation induced by U46619, a TXA2 analogue [J].
Cho, Hyun Jeong ;
Cho, Jae Youl ;
Rhee, Man Hee ;
Lim, Chang Ryul ;
Park, Hwa Jin .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (12) :1677-1682
[9]  
Cho HJ, 2007, J MICROBIOL BIOTECHN, V17, P1134
[10]   Cordycepin (3′-deoxyadenosine) inhibits human platelet aggregation in a cyclic AMP- and cyclic GMP-dependent manner [J].
Cho, Hyun-Jeong ;
Cho, Jae Youl ;
Rhee, Man Hee ;
Park, Hwa-Jin .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 558 (1-3) :43-51